by molly | Apr 24, 2024 | Media
New Drosophila screening lab further expands RxCelerate’s drug discovery and development capabilities Cambridge, UK Wednesday 24th April 2024, 9AM GMT RxCelerate is excited to launch our new fly screening service, further expanding the bespoke and flexible drug...
by molly | Jun 15, 2023 | Media
RxCelerate a power behind many drug development thrones Cambridge, UK – January 23, 2020 BioMed Realty (“BioMed Realty” or the “Company”), a Blackstone portfolio company and a leading provider of real estate solutions to the life sciences community, and RxCelerate,...
by admin | Nov 22, 2022 | Media
RxCelerate acquires Methuselah Health and launches ProQuant™ world-beating proteomics service Cambridge, UK and Cambridge, MA Tuesday 22nd November 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today announced...
by admin | Jul 19, 2022 | Media
RxCelerate launch RxNfinity™: a next-generation machine learning-enabled small molecule discovery platform Cambridge, UK and Cambridge, MA – Tuesday 19th July 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today...
by admin | Feb 16, 2021 | Media
RxCelerate launch Galaxy™: a next-generation antibody discovery platform Cambridge, UK and Cambridge, MA – Tuesday 16th February 2021, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new...
by admin | Jan 20, 2020 | Media
RxCelerate expands space to 25,000 square feet Cambridge, UK – January 23, 2020 BioMed Realty (“BioMed Realty” or the “Company”), a Blackstone portfolio company and a leading provider of real estate solutions to the life sciences community, and RxCelerate, one of the...
